Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

For our comprehensive coverage and latest updates on COVID-19 click here.

J&J said in a statement on 21 September that it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults from age 18 to 55. The study's results haven't yet been peer-reviewed.

A booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine, said Dr. Mathai Mammen, global head of research and development at J&J.

The company is in talks with regulators including the US Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine.